Abiopharma

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum

Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference

GSK plc (GLAXF) Files Form 6-K

(90% Positive) MONTE ROSA THERAPEUTICS, INC. (GLUE) Provides Update on development for today at 8 a

Genprex Provides Clinical Update on Diabetes Gene Therapy Program

10x Genomics - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

(30% Negative) EyePoint, Inc. (EYPT) Announces Delay in Conference Trials for San Francisco on Tuesday Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

CareDx - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

(99% Neutral) GENPREX, INC. (GNPX) Files Form 8-K